Advanced search
Publication Cover
Artificial Cells, Nanomedicine, and Biotechnology
An International Journal
Volume 46, 2018 - Issue sup3
Submit an article Journal homepage
2,470
Views
33
CrossRef citations to date
0
Altmetric
Research Article

The combined administration of parthenolide and ginsenoside CK in long circulation liposomes with targeted tLyp-1 ligand induce mitochondria-mediated lung cancer apoptosis

Xin Jina Department of Hospital Pharmacy, Suqian Branch Jiangsu Province Hospital, Suqian, China;b Department of Pharmaceutics, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, ChinaView further author information
,
Jianping Zhoub Department of Pharmaceutics, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, ChinaView further author information
,
Zhenhai Zhangc Jiangsu Province Hospital on Integration of Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, ChinaCorrespondence[email protected]
View further author information
&
Huixia Lvb Department of Pharmaceutics, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, ChinaCorrespondence[email protected]
View further author information
Pages 931-942 | Received 23 Jul 2018, Accepted 28 Aug 2018, Published online: 11 Oct 2018

Citations (33)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Tao An, Huanhuan Yin, Yanting Lu & Feng Liu. (2022) The Emerging Potential of Parthenolide Nanoformulations in Tumor Therapy. Drug Design, Development and Therapy 16, pages 1255-1272.
Read now
Israa A. Cheikh, Chirine El-Baba, Ali Youssef, Najat A. Saliba, Akram Ghantous & Nadine Darwiche. (2022) Lessons learned from the discovery and development of the sesquiterpene lactones in cancer therapy and prevention. Expert Opinion on Drug Discovery 17:12, pages 1377-1405.
Read now

Articles from other publishers (31)

Mohammad Sameer Khan, B.H. Jaswanth Gowda, Waleed H. Almalki, Tanuja Singh, Amirhossein Sahebkar & Prashant Kesharwani. (2024) Unravelling the potential of mitochondria-targeted liposomes for enhanced cancer treatment. Drug Discovery Today 29:1, pages 103819.
Crossref
Lina Wang, Yanxin Zhang, Zhimin Song, Qingchao Liu, Daidi Fan & Xiaoping Song. (2023) Ginsenosides: a potential natural medicine to protect the lungs from lung cancer and inflammatory lung disease. Food & Function 14:20, pages 9137-9166.
Crossref
Lindokuhle M. Ngema, Samson A. Adeyemi, Thashree Marimuthu, Philemon N. Ubanako, Wilfred Ngwa & Yahya E. Choonara. (2023) Surface Immobilization of Anti-VEGF Peptide on SPIONs for Antiangiogenic and Targeted Delivery of Paclitaxel in Non-Small-Cell Lung Carcinoma. ACS Applied Bio Materials 6:7, pages 2747-2759.
Crossref
Jessica E. Holder, Christopher Ferguson, Elisabete Oliveira, Carlos Lodeiro, Carol M. Trim, Lee J. Byrne, Emilia Bertolo & Cornelia M. Wilson. (2023) The use of nanoparticles for targeted drug delivery in non-small cell lung cancer. Frontiers in Oncology 13.
Crossref
Ahmed Ibrahim Albosultan, Maryam Ghobeh & Masoud Homayouni Tabrizi. (2023) The Anticancer, Anti-metastatic, Anti-oxidant, and Anti-angiogenic Activity of Chitosan-coated Parthenolide/Bovine Serum Albumin Nanoparticles. Journal of Inorganic and Organometallic Polymers and Materials 33:3, pages 841-852.
Crossref
Lu Ding, Hongyu Qi, Yisa Wang, Zepeng Zhang, Qing Liu, Chen Guo, Jiaqi Liu, Zhaoqiang Chen, Jing Li, JinJin Chen, Qingxia Huang, Daqing Zhao, Zeyu Wang & Xiangyan Li. (2023) Recent advances in ginsenosides against respiratory diseases: Therapeutic targets and potential mechanisms. Biomedicine & Pharmacotherapy 158, pages 114096.
Crossref
Wang Yao & Yunfeng Guan. (2022) Ginsenosides in cancer: A focus on the regulation of cell metabolism. Biomedicine & Pharmacotherapy 156, pages 113756.
Crossref
Mohanapriya Murugesan, Ramya Mathiyalagan, Vinothini Boopathi, Byoung Man Kong, Sung-Keun Choi, Chang-Soon Lee, Deok Chun Yang, Se Chan Kang & Thavasyappan Thambi. (2022) Production of Minor Ginsenoside CK from Major Ginsenosides by Biotransformation and Its Advances in Targeted Delivery to Tumor Tissues Using Nanoformulations. Nanomaterials 12:19, pages 3427.
Crossref
Wamidh H. Talib, Dima Awajan, Reem Ali Hamed, Aya O. Azzam, Asma Ismail Mahmod & Intisar Hadi AL-Yasari. (2022) Combination Anticancer Therapies Using Selected Phytochemicals. Molecules 27:17, pages 5452.
Crossref
Yue Ke, Lei Huang, Yu Song, Zhenxin Liu, Linshuang Liang, Linmao Wang & Taoyun Wang. (2022) Preparation and pharmacological effects of minor ginsenoside nanoparticles: a review. Frontiers in Pharmacology 13.
Crossref
Xiamin Cheng, Hui Yan, Songhao Pang, Mingjun Ya, Feng Qiu, Pinzhu Qin, Chao Zeng & Yongna Lu. (2022) Liposomes as Multifunctional Nano-Carriers for Medicinal Natural Products. Frontiers in Chemistry 10.
Crossref
Yubo Dong, Xuanjin Qian & Jian Li. (2022) Sesquiterpene Lactones and Cancer: New Insight into Antitumor and Anti-inflammatory Effects of Parthenolide-Derived Dimethylaminomicheliolide and Micheliolide. Computational and Mathematical Methods in Medicine 2022, pages 1-8.
Crossref
Zhaoqiang Chen, Zepeng Zhang, Jiaqi Liu, Hongyu Qi, Jing Li, Jinjin Chen, Qingxia Huang, Qing Liu, Jia Mi & Xiangyan Li. (2022) Gut Microbiota: Therapeutic Targets of Ginseng Against Multiple Disorders and Ginsenoside Transformation. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Li Zhou, Zhong‐Kun Li, Cong‐Yuan Li, Yue‐Qin Liang & Fan Yang. (2021) Anticancer properties and pharmaceutical applications of ginsenoside compound K: A review. Chemical Biology & Drug Design 99:2, pages 286-300.
Crossref
Jingyue Wang, Tong Zhou, Ying Liu, Shuangmin Chen & Zhenxiang Yu. (2022) Application of Nanoparticles in the Treatment of Lung Cancer With Emphasis on Receptors. Frontiers in Pharmacology 12.
Crossref
Fang Yang, Ming-Yue Yang, Jing-Qing Le, Bang-Yue Luo, Meng-Die Yin, Chao-Li, Jia-Li Jiang, Yi-Fan Fang & Jing-Wei Shao. (2022) Protective Effects and Therapeutics of Ginsenosides for Improving Endothelial Dysfunction: From Therapeutic Potentials, Pharmaceutical Developments to Clinical Trials. The American Journal of Chinese Medicine 50:03, pages 749-772.
Crossref
Hong Wang, Yu Zheng, Qiang Sun, Zhen Zhang, Mengnan Zhao, Cheng Peng & Sanjun Shi. (2021) Ginsenosides emerging as both bifunctional drugs and nanocarriers for enhanced antitumor therapies. Journal of Nanobiotechnology 19:1.
Crossref
Qingxia Huang, Song Gao, Daqing Zhao & Xiangyan Li. (2021) Review of ginsenosides targeting mitochondrial function to treat multiple disorders: Current status and perspectives. Journal of Ginseng Research 45:3, pages 371-379.
Crossref
Sukanya Ghosh & Manidipa Banerjee. (2021) A smart viral vector for targeted delivery of hydrophobic drugs. Scientific Reports 11:1.
Crossref
Heeok Hong, Delgerzul Baatar & Seong Gu Hwang. (2021) Anticancer Activities of Ginsenosides, the Main Active Components of Ginseng. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-10.
Crossref
Jing Zhao, Zhiguang Duan, Xiaoxuan Ma, Yannan Liu & Daidi Fan. (2021) Recent advances in systemic and local delivery of ginsenosides using nanoparticles and nanofibers. Chinese Journal of Chemical Engineering 30, pages 291-300.
Crossref
Wei Wang, Yuhao Hao, Yusheng Liu, Rui Li, Da‐Bing Huang & Yue‐Yin Pan. (2020) Nanomedicine in lung cancer: Current states of overcoming drug resistance and improving cancer immunotherapy. WIREs Nanomedicine and Nanobiotechnology 13:1.
Crossref
Wenxiu Qi, Xiuci Yan, Xiaohao Xu, Bailin Song, Liping Sun, Daqing Zhao & Liwei Sun. (2020) The effects of cytarabine combined with ginsenoside compound K synergistically induce DNA damage in acute myeloid leukemia cells. Biomedicine & Pharmacotherapy 132, pages 110812.
Crossref
Thaise Gonçalves Araújo, Lara Vecchi, Paula Marynella Alves Pereira Lima, Everton Allan Ferreira, Igor Moreira Campos, Douglas Cardoso Brandão, Gabriela Silva Guimarães, Matheus Alves Ribeiro & Ademar Alves da Silva Filho. (2020) Parthenolide and its Analogues: A New Potential Strategy for the Treatment of Triple-Negative Breast Tumors. Current Medicinal Chemistry 27:39, pages 6628-6642.
Crossref
Wamidh H. Talib, Izzeddin Alsalahat, Safa Daoud, Reem Fawaz Abutayeh & Asma Ismail Mahmod. (2020) Plant-Derived Natural Products in Cancer Research: Extraction, Mechanism of Action, and Drug Formulation. Molecules 25:22, pages 5319.
Crossref
Anshul Sharma & Hae-Jeung Lee. (2020) Ginsenoside Compound K: Insights into Recent Studies on Pharmacokinetics and Health-Promoting Activities. Biomolecules 10:7, pages 1028.
Crossref
Pan Liang, Hangyi Wu, Zhenhai Zhang, Shulong Jiang & Huixia Lv. (2020) Preparation and characterization of parthenolide nanocrystals for enhancing therapeutic effects of sorafenib against advanced hepatocellular carcinoma. International Journal of Pharmaceutics 583, pages 119375.
Crossref
Laila Moujir, Oliver Callies, Pedro M. C. Sousa, Farukh Sharopov & Ana M. L. Seca. (2020) Applications of Sesquiterpene Lactones: A Review of Some Potential Success Cases. Applied Sciences 10:9, pages 3001.
Crossref
Mohammad A. Ansari, Khan F. Badrealam, Asrar Alam, Saba Tufail, Gulshan Khalique, Mohammad J. Equbal, Mohammad A. Alzohairy, Ahmad Almatroudi, Mohammad N. Alomary & Faheem H. Pottoo. (2020) Recent Nano-based Therapeutic Intervention of Bioactive Sesquiterpenes: Prospects in Cancer Therapeutics. Current Pharmaceutical Design 26:11, pages 1138-1144.
Crossref
Jing Zhang, Xiang Li & Leaf Huang. (2020) Anticancer activities of phytoconstituents and their liposomal targeting strategies against tumor cells and the microenvironment. Advanced Drug Delivery Reviews 154-155, pages 245-273.
Crossref
Xin Jin, Jianping Zhou, Zhenhai Zhang & Huixia Lv. (2019) Doxorubicin combined with betulinic acid or lonidamine in RGD ligand-targeted pH-sensitive micellar system for ovarian cancer treatment. International Journal of Pharmaceutics 571, pages 118751.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.